Takeover Arkema to Sell Phosphorus Derivatives Business to Belgian Firm

Source: Press release Arkema

Related Vendors

Arkema has plans to divest its phosphorus derivatives business – Febex to the Belgian group Prayon which is an expert in phosphorus-based chemistry. The deal is expected to be finalized in the first quarter 2023.

Febex is a global player in phosphorus derivatives which is used primarily in electronics and in the pharmaceuticals industry.
Febex is a global player in phosphorus derivatives which is used primarily in electronics and in the pharmaceuticals industry.
(Source: Pixabay)

Colombes/France – Arkema has recently announced the proposed divestment of Febex, a company specialized in phosphorus-based chemistry, to Belgian group Prayon. Arkema thus continues its dynamic business portfolio management.

Febex is a global player in phosphorus derivatives (high purity phosphoric acid, sodium hypophosphite and derivatives), used primarily in electronics and in the pharmaceuticals industry. Part of the Performance Additives Business Line and with little integration within the Group’s other activities, Febex reported sales of around 30 million euros in 2021, employs 59 people, and operates 1 site in Switzerland.

By joining Prayon, an industrial group specialized in phosphorus-based chemistry, the Febex teams will benefit from the Belgian group’s growth ambitions in this area.

This project, which is expected to be finalized in 1st quarter 2023, is subject to information and prior consultation process with employee representative bodies in France and to approval by the relevant Swiss authorities.

(ID:48727518)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent